Excessive centrosome abnormalities without ongoing numerical chromosome instability in a Burkitt's lymphoma
© Duensing et al; licensee BioMed Central Ltd. 2003
Received: 27 June 2003
Accepted: 08 September 2003
Published: 08 September 2003
Numerical and structural centrosome abnormalities are detected in various human malignancies and have been implicated in the formation of multipolar mitoses, chromosome missegregation, and chromosomal instability. Despite this association between centrosome abnormalities and cancerous growth, a causative role of centrosome aberrations in generating chromosomal instability and aneuploidy has not been universally established. We report here excessive numerical and structural centrosome abnormalities in a malignant Burkitt's lymphoma harboring the characteristic t(8;14) chromosomal translocation. Using conventional karyotyping and fluorescence in situ hybridization (FISH), we detected no signs of ongoing numerical chromosome instability, although the tumor displayed sporadic multipolar metaphases. These findings demonstrate that centrosome abnormalities are not a universal surrogate marker for chromosomal instability in malignant tumors. Moreover, our results suggest a model in which additional cellular alterations may be required to promote centrosome-related mitotic defects in tumor cells.
Numerical and structural centrosome abnormalities are hallmarks of various cancers and have been implicated in the generation of multipolar mitoses and chromosomal instability [1, 2]. Centrosomes function as major microtubule organizing centers in animal and human cells and thus contribute importantly to proper spindle formation and function during mitosis . Normally, the single centrosome of a G1 cell duplicates precisely once prior to mitosis in a process that is intimately linked to the cell division cycle . Accurate control of centrosome duplication is critical for symmetric mitotic spindle formation and thereby contributes to the maintenance of genome integrity.
Various oncogenic stimuli have been associated with abnormal centrosome numbers . Centrosome alterations in tumor cells are believed to lead to multipolar mitosis, asymmetric chromosome segregation and aneuploidy [2, 6]. For most cancers, however, the association between centrosome aberrations and malignant progression is merely based on correlation and a causative role of centrosome abnormalities in establishing and maintaining numerical chromosome instability as defined by dynamic changes in chromosome copy numbers  has not been universally established .
Analysis of centrosome abnormalities was performed using immunofluorescence microscopy for the pericentriolar marker γ-tubulin . Briefly, tissue sections were deparaffinized in xylene and dehydrated in ethanol. Slides were then boiled in 10 mM citrate buffer (pH 6.0) for 30 min in a microwave oven followed by digestion with Digest-All-3 pepsin solution (Zymed) for 5 min at 37°C. Slides were blocked with 10% normal donkey serum (Jackson Immunoresearch) for 15 min at room temperature followed by incubation with a mouse monoclonal anti-γ-tubulin antibody (GTU-88; Sigma) at a 1:1000 dilution overnight at 4°C. After washing in PBS, sections were incubated with a donkey anti-mouse rhodamine red conjugated secondary antibody (Jackson Immunoresearch) at a 1:100 dilution in PBS for 2 hours at 37°C. Cells were finally washed in PBS, counterstained with DAPI (Vector), and analyzed by epifluorescence microscopy. Since normal centrosome duplication gives rise to two centrosomes per cell, cells with more than two γ-tubulin dots were considered abnormal. In addition, structural centrosome abnormalities as characterized by deviations from the typical dot-like staining pattern were assessed.
To investigate whether the observed centrosome abnormalities were associated with ongoing numerical chromosome instability, chromosome 11 copy numbers were analyzed by fluorescence in situ hybridization (FISH). Chromosome 11 copy number changes are among the five most frequently found numerical chromosome abnormalities in Burkitt's lymphoma karyotypes retrieved from the CGAP database . For interphase FISH, a Spectrum Green-labeled chromosome 11 α-satellite probe (D11Z1) was used according to the manufacturer's protocol (Vysis). None out of more than one-thousand cells analyzed showed more than two copies of chromosome 11 (Fig. 2E). Consistent with this observation, cytogenetic analysis revealed a single predominant pseudo-diploid karyotype: 46, XY, t(8;14)(q24;q32),-17, der(19)t(7;19)(q11.2;q13), +mar (Fig. 1B). This karyotype is in line with previous studies that showed no evidence for gross aneuploidy in most Burkitt's lymphomas . The absence of ongoing numerical chromosome instability was not due to impaired proliferative activity as evidenced by the high mitotic index (Fig. 1A).
Taken together, our results show that centrosome abnormalities do not necessarily correlate with ongoing numerical chromosome instability and that even the presence of multipolar metaphases is not sufficient to predict whether a cell or a tumor is chromosomally unstable. This indicates that numerical chromosome stability can be maintained in a tumor despite high-level centrosome abnormalities. In conclusion, the impact of centrosome abnormalities on genomic destabilization and malignant progression needs to be analyzed in the context of the cellular background in which these alterations occur.
The question why a tumor cell with centrosome abnormalities does not necessarily acquire numerical chromosome imbalances may have several answers. In general, two models that lead to centrosome abnormalities with distinct functional consequences can be envisioned . According to the first model, numerical centrosome abnormalities can arise as a consequence of abortive mitotic events and impaired cytokinesis [14–16]. Under such conditions, centrosome abnormalities are unlikely to cause expansion of a population of genomically unstable tumor cells because such cells are unable to complete mitosis and to give rise to viable progeny. In striking contrast, studies in breast cancer and primary human cell populations expressing the human papillomavirus type 16 (HPV-16) E7 oncoprotein provided evidence that abnormal centrosome duplication can precede genomic destabilization and arise in morphologically normal cells with functional p53 [15, 17]. Such cells have no inherent cell division defects, and thus, they are more likely to undergo abnormal mitosis even though additional checkpoint mechanisms may need to be subverted in order to give rise to chromosomally unstable daughter cells. In support of the notion that abnormal centrosome numbers and multipolar mitoses do not necessarily cause genomic instability, it has been shown that in HPV E7-expressing cells there are dramatic quantitative differences between multipolar metaphase cells and cells with a multipolar ana- or telophase configuration [18, 19]. A similar finding is presented here where multipolar anaphases were undetectable despite approximately 5% of multipolar metaphase cells (Fig. 2B,2C,2D). The molecular basis for a hypothetical checkpoint that halts mitotic progression in the presence of multiple spindle poles has not yet been established . Although p53 has been implicated in a post-mitotic checkpoint following spindle disruption , results presented here and reports by others [22, 23] suggest that checkpoint mechanisms other than p53 are involved in suppressing aneuploidy. This does not rule out that p53 inactivation contributes indirectly to genomic destabilization  by interfering with apoptotic cell death and thus allowing chromosomally unstable cells to remain in the proliferative pool. Another mechanism that may limit chromosome missegregation in the presence of multiple spindle poles involves coalescence of centrosomes whereby a bipolar spindle is formed by clusters of multiple centrosomes .
Overexpression of c-MYC in vitro has been shown to result in structural chromosomal aberrations  and DNA damage . Structural chromosome abnormalities in addition to the t(8;14) translocation are frequently detected in Burkitt's lymphoma including the case presented here. These findings, together with the observed loss of one copy of chromosome 17, may indicate that chromosomal instability might have been present at earlier stages of lymphomagenesis.
Since overexpression of c-MYC can cause a G2/M arrest and polyploidization [28, 29], accumulation of centrosomes in cells with impaired mitotic progression likely accounts for the majority of cells with centrosome abnormalities. Whether the c-MYC oncogene can directly contribute to the formation of multiple centrosomes in otherwise normal cells as it has been shown for the HPV-16 E7 oncoprotein  awaits further clarification.
In summary, our results show that numerical and/or structural centrosome abnormalities are not a universal surrogate marker for chromosomal instability. Further studies are warranted to investigate whether other cancers show a similar lack of correlation between centrosome abnormalities and numerical chromosome instability. Moreover, our study suggests that cellular mechanisms other than p53 inactivation may interfere with progression through mitosis in the presence of centrosome-related cell division defects. Further investigations addressing these problems will help to lead to a more definitive model of the role of centrosome abnormalities in cancer development and progression.
Author 1 (S. D.) coordinated the study and performed immunofluorescence analysis of centrosomes and FISH. Author 2 (B. H. L.) participated in the histological diagnosis of the lymphoma and also in the collection of tumor material and clinical information, and provided the hematoxylin & eosin image. Author 3 (P. D. C.) performed the cytogenetic analysis and diagnosis of the malignant lymphoma and provided the image of the karyotype. Author 4 (K. M.) participated in the design and interpretation of the study. All authors read and approved the final manuscript.
G-bands obtained with trypsin and Giemsa
hematoxylin & eosin
Supported by a research grant from AstraZeneca to K. M. S. D. was supported by a research fellowship of the Deutsche Forschungsgemeinschaft.
- Pihan GA, Purohit A, Wallace J, Knecht H, Woda B, Quesenberry P, Doxsey SJ: Centrosome defects and genetic instability in malignant tumors. Cancer Res. 1998, 58: 3974-3985.PubMedGoogle Scholar
- Salisbury JL, Whitehead CM, Lingle WL, Barrett SL: Centrosomes and cancer. Biol Cell. 1999, 91: 451-460. 10.1016/S0248-4900(99)80086-0View ArticlePubMedGoogle Scholar
- Kellogg DR, Moritz M, Alberts BM: The centrosome and cellular organization. Annu Rev Biochem. 1994, 63: 639-674. 10.1146/annurev.bi.63.070194.003231View ArticlePubMedGoogle Scholar
- Hinchcliffe EH, Sluder G: "It takes two to tango": understanding how centrosome duplication is regulated throughout the cell cycle. Genes Dev. 2001, 15: 1167-1181. 10.1101/gad.894001View ArticlePubMedGoogle Scholar
- Duensing S, Munger K: Centrosome abnormalities, genomic instability and carcinogenic progression. Biochim Biophys Acta. 2001, 1471: M81-M88. 10.1016/S0304-419X(00)00025-1PubMedGoogle Scholar
- Nigg EA: Centrosome aberrations: cause or consequence of cancer progression?. Nat Rev Cancer. 2002, 2: 1-11. 10.1038/nrc924.View ArticleGoogle Scholar
- Lengauer C, Kinzler KW, Vogelstein B: Genetic instabilities in human cancers. Nature. 1998, 396: 643-649. 10.1038/25292View ArticlePubMedGoogle Scholar
- Klein G: Specific chromosomal translocations and the genesis of B-cell-derived tumors in mice and men. Cell. 1983, 32: 311-315.View ArticlePubMedGoogle Scholar
- Stearns T, Evans L, Kirschner M: Gamma-tubulin is a highly conserved component of the centrosome. Cell. 1991, 65: 825-836.View ArticlePubMedGoogle Scholar
- Mitelman Database of Chromosome Aberrations in Cancer. Edited by: Mitelman F, Johansson B, Mertens F. 2003, http://cgap.nci.nih.gov/Chromosomes/Mitelman
- Gaidano G, Ballerini P, Gong JZ, Inghirami G, Neri A, Newcomb EW, Magrath IT, Knowles DM, Dalla-Favera R: p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia. Proc Natl Acad Sci USA. 1991, 88: 5413-5417.PubMed CentralView ArticlePubMedGoogle Scholar
- Iggo R, Gatter K, Bartek J, Lane D, Harris AL: Increased expression of mutant forms of p53 oncogene in primary lung cancer. Lancet. 1990, 335: 675-679. 10.1016/0140-6736(90)90801-BView ArticlePubMedGoogle Scholar
- Duensing S, Munger K: Human papillomaviruses and centrosome duplication errors: modeling the origins of genomic instability. Oncogene. 2002, 21: 6241-6248. 10.1038/sj.onc.1205709View ArticlePubMedGoogle Scholar
- Bunz F, Dutriaux A, Lengauer C, Waldman T, Zhou S, Brown JP, Sedivy JM, Kinzler KW, Vogelstein B: Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science. 1998, 282: 1497-1501. 10.1126/science.282.5393.1497View ArticlePubMedGoogle Scholar
- Duensing S, Duensing A, Crum CP, Munger K: Human papillomavirus type 16 E7 oncoprotein-induced abnormal centrosome synthesis is an early event in the evolving malignant phenotype. Cancer Res. 2001, 61: 2356-2360.PubMedGoogle Scholar
- Meraldi P, Honda R, Nigg EA: Aurora-A overexpression reveals tetraploidization as a major route to centrosome amplification in p53-/- cells. EMBO J. 2002, 21: 483-492. 10.1093/emboj/21.4.483PubMed CentralView ArticlePubMedGoogle Scholar
- Lingle WL, Barrett SL, Negron VC, D'Assoro AB, Boeneman K, Liu W, Whitehead CM, Reynolds C, Salisbury JL: Centrosome amplification drives chromosomal instability in breast tumor development. Proc Natl Acad Sci USA. 2002, 99: 1978-1983. 10.1073/pnas.032479999PubMed CentralView ArticlePubMedGoogle Scholar
- Duensing S, Lee LY, Duensing A, Basile J, Piboonniyom S, Gonzalez S, Crum CP, Munger K: The human papillomavirus type 16 E6 and E7 oncoproteins cooperate to induce mitotic defects and genomic instability by uncoupling centrosome duplication from the cell division cycle. Proc Natl Acad Sci USA. 2000, 97: 10002-10007. 10.1073/pnas.170093297PubMed CentralView ArticlePubMedGoogle Scholar
- Duensing S, Münger K: The human papillomavirus type 16 E6 and E7 oncoproteins independently induce numerical and structural chromosome instability. Cancer Res. 2002, 62: 7075-7082.PubMedGoogle Scholar
- Sluder G, Thompson EA, Miller FJ, Hayes J, Rieder CL: The checkpoint control for anaphase onset does not monitor excess numbers of spindle poles or bipolar spindle symmetry. J Cell Sci. 1997, 110: 421-429.PubMedGoogle Scholar
- Lanni JS, Jacks T: Characterization of the p53-dependent postmitotic checkpoint following spindle disruption. Mol Cell Biol. 1998, 18: 1055-1064.PubMed CentralPubMedGoogle Scholar
- Lu X, Magrane G, Yin C, Louis DN, Gray J, Van Dyke T: Selective inactivation of p53 facilitates mouse epithelial tumor progression without chromosomal instability. Mol Cell Biol. 2001, 21: 6017-6030. 10.1128/MCB.21.17.6017-6030.2001PubMed CentralView ArticlePubMedGoogle Scholar
- Bunz F, Fauth C, Speicher MR, Dutriaux A, Sedivy JM, Kinzler KW, Vogelstein B, Lengauer C: Targeted inactivation of p53 in human cells does not result in aneuploidy. Cancer Res. 2002, 62: 1129-1133.PubMedGoogle Scholar
- Yin XY, Grove L, Datta NS, Long MW, Prochownik EV: c-Myc overexpression and p53 loss cooperate to promote genomic instability. Oncogene. 1999, 18: 1177-1184. 10.1038/sj.onc.1202410View ArticlePubMedGoogle Scholar
- Brinkley BR: Managing the centrosome numbers game: from chaos to stability in cancer cell division. Trends Cell Biol. 2001, 11: 18-21. 10.1016/S0962-8924(00)01872-9View ArticlePubMedGoogle Scholar
- Mai S, Fluri M, Siwarski D, Huppi K: Genomic instability in MycER-activated Rat1A-MycER cells. Chromosome Res. 1996, 4: 365-371.View ArticlePubMedGoogle Scholar
- Vafa O, Wade M, Kern S, Beeche M, Pandita TK, Hampton GM, Wahl GM: c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: a mechanism for oncogene-induced genetic instability. Mol Cell. 2002, 9: 1031-1044.View ArticlePubMedGoogle Scholar
- Felsher DW, Bishop JM: Transient excess of MYC activity can elicit genomic instability and tumorigenesis. Proc Natl Acad Sci USA. 1999, 96: 3940-3944. 10.1073/pnas.96.7.3940PubMed CentralView ArticlePubMedGoogle Scholar
- Felsher DW, Zetterberg A, Zhu J, Tlsty T, Bishop JM: Overexpression of MYC causes p53-dependent G2 arrest of normal fibroblasts. Proc Natl Acad Sci USA. 2000, 97: 10544-10548. 10.1073/pnas.190327097PubMed CentralView ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.